Tapewire

NYSE · USD

UNH

UNITEDHEALTH GROUP INC

Export transactions ↓
Tapewire entity
2809
SEC CIK
0000731766
Parsed reports
3,134

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 27, 2023 Filed May 1, 2023 20:45 UTC
WITTY ANDREWDirector · CEO, UHG
SaleCommon Stock 6,160 $487.49 $3,002,949.49
Disclosure

SEC source: 0001209191-23-026294 · doc4.xml · nonDerivative · entry 1

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,563.916

F1 · price: This transaction was executed in multiple trades ranging from $487.39 to $487.59 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
April 25, 2023 Filed Apr 25, 2023 23:00 UTC
McSweeney ErinEVP Chief People Officer
SaleCommon Stock 761 $494.80 $376,542.80
Disclosure

SEC source: 0001209191-23-025620 · doc4.xml · nonDerivative · entry 5

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,293.409

Read SEC document
April 24, 2023 Filed Apr 25, 2023 23:00 UTC
McSweeney ErinEVP Chief People Officer
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative 6,000 $0.00 Strike: $302.20 $0.00
Disclosure

SEC source: 0001209191-23-025620 · doc4.xml · derivative · entry 6

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,248

Underlying: Common Stock · 6,000 shares

Expires 2030-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The non-qualified stock options vested at a rate of 25% annually on February 13 from the years 2021 through 2024.

Read SEC document
April 24, 2023 Filed Apr 25, 2023 23:00 UTC
McSweeney ErinEVP Chief People Officer
Tax withholdingCommon Stock 4,621 $486.60 $2,248,578.60
Disclosure

SEC source: 0001209191-23-025620 · doc4.xml · nonDerivative · entry 4

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,054.409

Read SEC document
April 24, 2023 Filed Apr 25, 2023 23:00 UTC
McSweeney ErinEVP Chief People Officer
Exercise / conversionCommon Stock 6,000 $302.20 $1,813,200.00
Disclosure

SEC source: 0001209191-23-025620 · doc4.xml · nonDerivative · entry 3

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,675.409

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2023 Filed Apr 25, 2023 23:00 UTC
McSweeney ErinEVP Chief People Officer
SaleCommon Stock 1,684 $488.46 $822,561.92
Disclosure

SEC source: 0001209191-23-025620 · doc4.xml · nonDerivative · entry 2

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,675.409

F1 · price: This transaction was executed in multiple trades ranging from approximately $487.35 to $489.80 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 23:00 UTC
McSweeney ErinEVP Chief People Officer
SaleCommon Stock 1,008 $484.58 $488,456.64
Disclosure

SEC source: 0001209191-23-025620 · doc4.xml · nonDerivative · entry 1

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,359.409

Read SEC document
April 19, 2023 Filed Apr 21, 2023 21:40 UTC
McSweeney ErinEVP Chief People Officer
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative 5,345 $0.00 Strike: $262.98 $0.00
Disclosure

SEC source: 0001209191-23-025227 · doc4.xml · derivative · entry 3

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,345

Underlying: Common Stock · 5,345 shares

Expires 2029-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The non-qualified stock options vested at a rate of 25% annually on February 26 from the years 2020 through 2023.

Read SEC document
April 19, 2023 Filed Apr 21, 2023 21:40 UTC
McSweeney ErinEVP Chief People Officer
Tax withholdingCommon Stock 3,840 $491.13 $1,885,939.20
Disclosure

SEC source: 0001209191-23-025227 · doc4.xml · nonDerivative · entry 2

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,367.409

Read SEC document
April 19, 2023 Filed Apr 21, 2023 21:40 UTC
McSweeney ErinEVP Chief People Officer
Exercise / conversionCommon Stock 5,345 $262.98 $1,405,628.10
Disclosure

SEC source: 0001209191-23-025227 · doc4.xml · nonDerivative · entry 1

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,207.409

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:05 UTC GrantCommon Stock 190 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023269 · doc4.xml · nonDerivative · entry 1

FLYNN TIMOTHY PATRICK · CIK 0001550322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,899

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:06 UTC GrantCommon Stock 64 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023272 · doc4.xml · nonDerivative · entry 2

GARCIA PAUL R · CIK 0001226012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,213

F2 · shares: Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:06 UTC GrantCommon Stock 114 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023272 · doc4.xml · nonDerivative · entry 1

GARCIA PAUL R · CIK 0001226012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,149

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:07 UTC
Gil KristenDirector
GrantCommon Stock 64 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023279 · doc4.xml · nonDerivative · entry 2

Gil Kristen · CIK 0001719411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222

F2 · shares: Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:07 UTC
Gil KristenDirector
GrantCommon Stock 114 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023279 · doc4.xml · nonDerivative · entry 1

Gil Kristen · CIK 0001719411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:08 UTC GrantCommon Stock 289 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023283 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 412,857.577

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:08 UTC GrantCommon Stock 114 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023289 · doc4.xml · nonDerivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,035

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:09 UTC GrantCommon Stock 194 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023294 · doc4.xml · nonDerivative · entry 1

MCNABB FREDERICK WILLIAM III · CIK 0001731814 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,961

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:10 UTC GrantCommon Stock 76 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023298 · doc4.xml · nonDerivative · entry 2

MONTGOMERY RICE VALERIE MD · CIK 0001714561 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,632

F2 · shares: Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:10 UTC GrantCommon Stock 114 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023298 · doc4.xml · nonDerivative · entry 1

MONTGOMERY RICE VALERIE MD · CIK 0001714561 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,556

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:10 UTC GrantCommon Stock 190 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023300 · doc4.xml · nonDerivative · entry 1

Noseworthy John H · CIK 0001706596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,141

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:15 UTC
WITTY ANDREWDirector · CEO, UHG
GrantCommon Stock 82.823 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020806 · doc4.xml · nonDerivative · entry 1

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,723.916

F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:16 UTC
THOMPSON BRIAN RCEO, UnitedHealthcare
GrantCommon Stock 42.013 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020807 · doc4.xml · nonDerivative · entry 1

THOMPSON BRIAN R · CIK 0001857198 · CEO, UnitedHealthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,651.806

F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:17 UTC
ROOS THOMAS EChief Accounting Officer
GrantCommon Stock 18.073 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020808 · doc4.xml · nonDerivative · entry 1

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,302.63

F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:18 UTC
REX JOHN FEVP Chief Financial Officer
GrantCommon Stock 62.496 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020809 · doc4.xml · nonDerivative · entry 1

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,360.145

F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:19 UTC
McSweeney ErinEVP Chief People Officer
GrantCommon Stock 24.144 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020810 · doc4.xml · nonDerivative · entry 1

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,862.409

F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:20 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
GrantCommon Stock 62.496 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020811 · doc4.xml · nonDerivative · entry 1

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,598.005

F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:21 UTC
Bondy Rupert MEVP & Chief Legal Officer
GrantCommon Stock 15.833 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020812 · doc4.xml · nonDerivative · entry 1

Bondy Rupert M · CIK 0001914476 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,256.584

F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:23 UTC GrantCommon Stock 25 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020813 · doc4.xml · nonDerivative · entry 1

FLYNN TIMOTHY PATRICK · CIK 0001550322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,709

F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:24 UTC GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020814 · doc4.xml · nonDerivative · entry 1

GARCIA PAUL R · CIK 0001226012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,035

F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:26 UTC GrantCommon Stock 17 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020817 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 412,568.577

F1 · shares: Represents dividend equivalents paid on vesting deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:27 UTC GrantCommon Stock 119 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020818 · doc4.xml · nonDerivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,921

F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:28 UTC GrantCommon Stock 19 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020820 · doc4.xml · nonDerivative · entry 1

MCNABB FREDERICK WILLIAM III · CIK 0001731814 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,767

F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:29 UTC GrantCommon Stock 15 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020821 · doc4.xml · nonDerivative · entry 1

MONTGOMERY RICE VALERIE MD · CIK 0001714561 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,442

F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:30 UTC GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020822 · doc4.xml · nonDerivative · entry 1

Noseworthy John H · CIK 0001706596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,951

F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:35 UTC
Gil KristenDirector
GrantCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-020824 · doc4.xml · nonDerivative · entry 1

Gil Kristen · CIK 0001719411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44

F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Read SEC document
February 24, 2023 Filed Feb 28, 2023 00:21 UTC
WITTY ANDREWDirector · CEO, UHG
Tax withholdingCommon Stock 1,155.996 $484.33 $559,883.54
Disclosure

SEC source: 0001209191-23-013400 · doc4.xml · nonDerivative · entry 4

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,641.093

Read SEC document
February 24, 2023 Filed Feb 28, 2023 00:22 UTC
THOMPSON BRIAN RCEO, UnitedHealthcare
Tax withholdingCommon Stock 460.13 $484.33 $222,854.76
Disclosure

SEC source: 0001209191-23-013402 · doc4.xml · nonDerivative · entry 4

THOMPSON BRIAN R · CIK 0001857198 · CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,609.793

Read SEC document
February 24, 2023 Filed Feb 28, 2023 00:24 UTC
REX JOHN FEVP Chief Financial Officer
Tax withholdingCommon Stock 791.445 $484.33 $383,320.56
Disclosure

SEC source: 0001209191-23-013403 · doc4.xml · nonDerivative · entry 4

REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,297.649

Read SEC document
February 24, 2023 Filed Feb 28, 2023 00:25 UTC
McMahon Dirk CPres. & COO, UHG & CEO, UHC
Tax withholdingCommon Stock 600.245 $484.33 $290,716.66
Disclosure

SEC source: 0001209191-23-013404 · doc4.xml · nonDerivative · entry 4

McMahon Dirk C · CIK 0001781821 · Pres. & COO, UHG & CEO, UHC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,535.509

Read SEC document
February 24, 2023 Filed Feb 28, 2023 00:27 UTC
ROOS THOMAS EChief Accounting Officer
Tax withholdingCommon Stock 422.328 $484.33 $204,546.12
Disclosure

SEC source: 0001209191-23-013405 · doc4.xml · nonDerivative · entry 2

ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,284.557

Read SEC document
February 24, 2023 Filed Feb 28, 2023 00:28 UTC
McSweeney ErinEVP Chief People Officer
Tax withholdingCommon Stock 397.063 $484.33 $192,309.52
Disclosure

SEC source: 0001209191-23-013406 · doc4.xml · nonDerivative · entry 2

McSweeney Erin · CIK 0001645325 · EVP Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,838.265

Read SEC document
February 24, 2023 Filed Feb 28, 2023 00:31 UTC Tax withholdingCommon Stock 999.085 $484.33 $483,886.84
Disclosure

SEC source: 0001209191-23-013408 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 412,551.577

F1 · balance_after: Excludes 1,075 shares previously owned directly which were contributed to GRAT #8 as set forth in footnote 2; 580 shares previously owned directly which were contributed to GRAT #9 as set forth in footnote 3; 1,350 shares previously owned directly which were contributed to GRAT #10 as set forth in footnote 4; 335 shares previously owned directly which were contributed to GRAT #11 as set forth in footnote 5; and 125,000 shares previously owned directly which were contributed to GRAT #12 as set forth in footnote 6. All share transfers took place on January 17, 2023. These transfers were exempt from Section 16 pursuant to Rule 16a-13.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:21 UTC
WITTY ANDREWDirector · CEO, UHG
GrantNon-Qualified Stock Options (right to buy) · Derivative 37,206 $0.00 Strike: $491.69 $0.00
Disclosure

SEC source: 0001209191-23-013400 · doc4.xml · derivative · entry 5

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,206

Underlying: Common Stock · 37,206 shares

Expires 2033-02-23

F4 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 23 from the years 2024 through 2027.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:21 UTC
WITTY ANDREWDirector · CEO, UHG
GrantCommon Stock 10,170 $491.69 $5,000,487.30
Disclosure

SEC source: 0001209191-23-013400 · doc4.xml · nonDerivative · entry 3

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,797.089

F3 · shares: The restricted stock units will vest at a rate of 25% annually on February 23 from the years 2024 through 2027.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:21 UTC
WITTY ANDREWDirector · CEO, UHG
Tax withholdingCommon Stock 9,994.505 $491.69 $4,914,198.16
Disclosure

SEC source: 0001209191-23-013400 · doc4.xml · nonDerivative · entry 2

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,627.089

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:21 UTC
WITTY ANDREWDirector · CEO, UHG
GrantCommon Stock 20,714 $491.69 $10,184,866.66
Disclosure

SEC source: 0001209191-23-013400 · doc4.xml · nonDerivative · entry 1

WITTY ANDREW · CIK 0001711304 · Director · CEO, UHG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,621.594

F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2020-2022.

F2 · balance_after: The number of shares has been adjusted due to prior inadvertent over-reporting of the total number of shares beneficially owned by the reporting person.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:22 UTC
THOMPSON BRIAN RCEO, UnitedHealthcare
GrantNon-Qualified Stock Options (right to buy) · Derivative 14,883 $0.00 Strike: $491.69 $0.00
Disclosure

SEC source: 0001209191-23-013402 · doc4.xml · derivative · entry 5

THOMPSON BRIAN R · CIK 0001857198 · CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,883

Underlying: Common Stock · 14,883 shares

Expires 2033-02-23

F4 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 23 from the years 2024 through 2027.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:22 UTC
THOMPSON BRIAN RCEO, UnitedHealthcare
GrantCommon Stock 4,068 $491.69 $2,000,194.92
Disclosure

SEC source: 0001209191-23-013402 · doc4.xml · nonDerivative · entry 3

THOMPSON BRIAN R · CIK 0001857198 · CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,069.923

F3 · shares: The restricted stock units will vest at a rate of 25% annually on February 23 from the years 2024 through 2027.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:22 UTC
THOMPSON BRIAN RCEO, UnitedHealthcare
Tax withholdingCommon Stock 4,414.08 $491.69 $2,170,359.00
Disclosure

SEC source: 0001209191-23-013402 · doc4.xml · nonDerivative · entry 2

THOMPSON BRIAN R · CIK 0001857198 · CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,001.923

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.